Luksika Jiramonai | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

Ms. Luksika Jiramonai | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

phD at National Center for Nanoscience and Technology, China

Luksika Jiramonai is a dedicated researcher in the fields of nanoscience, biotechnology, and biomedical sciences. Currently a PhD student at the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China, her work focuses on advancing therapeutic and diagnostic strategies in health sciences. She has a strong academic foundation with a Master’s degree in Applied Biological Sciences from Chulabhorn Graduate Institute, Thailand, and a Bachelor’s degree in Biotechnology from Mahidol University, Thailand. Over the years, Luksika has demonstrated a passion for applying her research in practical and transformative ways, particularly in the areas of disease resistance, nanotechnology, and molecular biology. With extensive research experience and an impressive track record of publications and awards, she is emerging as a promising scientist committed to solving global health challenges through innovation and scientific rigor.

Professional Profile

Education

Luksika Jiramonai has an impressive academic background, beginning with a Bachelor of Science in Biotechnology from Mahidol University, Thailand, where she explored molecular and bioprocess applications in biotechnology. She further pursued a Master of Science in Applied Biological Sciences at Chulabhorn Graduate Institute, Thailand, graduating with a cumulative GPA of 3.67/4.00. Her thesis, focused on oxidative stress responses in Stenotrophomonas maltophilia, showcases her early interest in microbiology and biotechnology. Building on this foundation, she is currently pursuing a PhD at the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, China. Her academic journey reflects a strong focus on interdisciplinary research with an emphasis on the intersection of molecular biology, nanotechnology, and medicine. This diverse education provides a solid platform for her ongoing contributions to the field.

Professional Experience

Luksika has accumulated diverse and extensive professional experience throughout her career. From 2019 to 2022, she worked as a Research Laboratory Technician at the Malaria Laboratory, Mahidol-Oxford Research Unit, where she investigated malaria and drug resistance, playing a key role in essential research aimed at combating infectious diseases. Prior to that, she served as a Research Assistant at the Molecular Clinical Pathology Laboratory, Department of Clinical Pathology at Siriraj Hospital, Thailand, where she contributed to projects focusing on cancer and oncolytic viruses. Luksika also held a position as a Research Assistant at Chulabhorn Graduate Institute, Thailand, contributing to research on bacterial oxidative stress and antibiotic resistance. Her early experience includes an internship at SGS Thailand, where she performed standardized testing on environmental and food samples. This broad range of experience underscores her adaptability and expertise in various biomedical research areas.

Research Interests

Luksika Jiramonai’s research interests center on molecular biology, nanotechnology, and their applications in healthcare. Her current PhD research delves into the development of nanoscience-based therapeutic strategies, particularly in cancer immunotherapy and drug resistance. She has explored a variety of critical scientific fields, including bacterial oxidative stress, drug resistance mechanisms in infectious diseases like malaria, and the application of nanocrystals in drug delivery systems. Additionally, her work on atherosclerosis models and their pathophysiology demonstrates her broad interest in chronic diseases and their biomedical implications. Luksika’s interdisciplinary approach integrates molecular biology with advanced nanotechnology, and her goal is to develop more targeted, effective treatments for complex health issues. Her research aims to bridge the gap between laboratory findings and real-world medical applications, contributing to better patient outcomes through innovative scientific discoveries.

Awards and Honors

Luksika Jiramonai has received notable recognition for her contributions to scientific research. She was honored with an honorable mention at the 8th Annual Conference on “Trends in Research on Environmental Health” in Thailand, underscoring the relevance of her research in environmental health. In 2018, she was a shortlisted candidate for poster presentation at the prestigious Thailand Merck Young Scientist Award, highlighting her potential as an emerging scientist. More recently, she has authored several review articles and research papers published in respected journals such as Pharmaceutics, iScience, and Antonie van Leeuwenhoek. Her research on nanocrystals, tumor immunotherapy, and atherosclerosis models has further established her as a rising star in the scientific community. These achievements underscore her commitment to advancing science and her recognition as a researcher capable of making significant impacts in biomedical research.

Conclusion

Luksika Jiramonai appears highly suitable for the Research for Young Scientist Award. She has demonstrated strong academic credentials, significant research experience, and published work that is relevant to important health challenges. Her background in interdisciplinary research on malaria, cancer, drug resistance, and nanotechnology positions her as a promising scientist for the future.

Publications Top Noted

  • Title: Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
    Authors: Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
    Year: 2025
    Journal: Pharmaceutics
    DOI: 10.3390/pharmaceutics17020257
    Citation: Jiramonai, L., Liang, X.-J., & Zhu, M. (2025). Extracellular Vesicle-Based Strategies for Tumor Immunotherapy. Pharmaceutics, 17(2), 257. https://doi.org/10.3390/pharmaceutics17020257

  • Title: The Development of Paliperidone Nanocrystals for the Treatment of Schizophrenia
    Authors: Phattalapol Lhaglham, Luksika Jiramonai, Xing-Jie Liang, Bingchuan Liu, Fangzhou Li
    Year: 2025
    Journal: Progress in Biomedical Engineering
    DOI: 10.1088/2516-1091/ad8fe7
    Citation: Lhaglham, P., Jiramonai, L., Liang, X.-J., Liu, B., & Li, F. (2025). The Development of Paliperidone Nanocrystals for the Treatment of Schizophrenia. Progress in Biomedical Engineering, 1(1), ad8fe7. https://doi.org/10.1088/2516-1091/ad8fe7

  • Title: Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery
    Authors: Phattalapol Lhaglham, Luksika Jiramonai, Yaru Jia, Baoying Huang, Yuanyu Huang, Xueyun Gao, Jinchao Zhang, Xing-Jie Liang, Mengliang Zhu
    Year: 2024
    Journal: iScience
    DOI: 10.1016/j.isci.2024.111185
    Citation: Lhaglham, P., Jiramonai, L., Jia, Y., Huang, B., Huang, Y., Gao, X., Zhang, J., Liang, X.-J., & Zhu, M. (2024). Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery. iScience, 11, 111185. https://doi.org/10.1016/j.isci.2024.111185

  • Title: Inactivation of ahpC Renders Stenotrophomonas maltophilia Resistant to the Disinfectant Hydrogen Peroxide
    Authors: Nisanart Charoenlap, Luksika Jiramonai, Jurairat Chittrakanwong, Naruemon Tunsakul, Skorn Mongkolsuk, Paiboon Vattanaviboon
    Year: 2019
    Journal: Antonie van Leeuwenhoek
    DOI: 10.1007/s10482-018-1203-9
    Citation: Charoenlap, N., Jiramonai, L., Chittrakanwong, J., Tunsakul, N., Mongkolsuk, S., & Vattanaviboon, P. (2019). Inactivation of ahpC Renders Stenotrophomonas maltophilia Resistant to the Disinfectant Hydrogen Peroxide. Antonie van Leeuwenhoek, 112(5), 757-764. https://doi.org/10.1007/s10482-018-1203-9

 

Christopher Milton Mathew | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Dr. Christopher Milton Mathew | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research Fellow at Franco Flinders University, Australia

Mariangela Di Vincenzo is an Italian biologist specializing in stem cell research, with a focus on the underlying mechanisms in Cushing’s syndrome and related disorders. Born on October 16, 1994, in Ancona, Italy, she has built a robust academic and professional trajectory within the scientific community. She currently serves as a research fellow at Marche Polytechnic University, where she is contributing to cutting-edge research in the field of human health, particularly involving stem cell dysfunctions in Cushing’s syndrome. Her academic journey and hands-on training have been instrumental in shaping her into a highly competent researcher. Her work has placed her at the intersection of molecular biology, histology, and clinical sciences, earning her recognition for her contributions to understanding complex pathologies and their cellular mechanisms. With a deep passion for science, she is positioning herself for significant contributions to medical advancements in the coming years.

Professional Profile

Education

Mariangela Di Vincenzo pursued her academic journey at Marche Polytechnic University in Italy, where she laid the foundation for her research career. She earned a Bachelor’s degree in Biological Sciences in 2017, followed by a Master’s degree in Molecular and Applied Biology in 2019, specializing in biological technologies. Her Master’s thesis focused on oxidative stress effects on embryo development in Danio Rerio, marking her first foray into experimental biology. Mariangela is currently completing her PhD in Human Health at Marche Polytechnic University under the supervision of Professors Monia Orciani and Giorgio Arnaldi, with her research dedicated to exploring mesenchymal stem cell dysfunctions in Cushing’s syndrome. The breadth of her education, coupled with specialized training in histology and medical technologies, has equipped her with a comprehensive understanding of biological systems and pathology, providing a strong foundation for her future academic and scientific endeavors.

Professional Experience

Mariangela’s professional career has been marked by significant research involvement at Marche Polytechnic University, where she has worked on several impactful research projects. Since November 2023, she has been a research fellow focusing on stem cell-based therapies for Cushing’s syndrome under the guidance of prominent professors in the field. Her role involves investigating the potential of stem cells as therapeutic targets in the treatment of complex diseases. Prior to this, she worked as a research fellow in 2020 on glucocorticoids and stem cells, further expanding her expertise in the dysregulated secretion of key molecules in various pathologies. Additionally, Mariangela has contributed to organizational roles in academic conferences, such as the GEISIBSC and SII Unified Conference in 2019. Her internships in histology and medically assisted reproduction have also refined her practical skills, making her well-versed in laboratory techniques and clinical research applications.

Research Interests

Mariangela Di Vincenzo’s research interests lie at the intersection of stem cell biology, endocrinology, and molecular pathology. Her primary focus is on understanding the dysfunctions of mesenchymal stem cells in Cushing’s syndrome, a condition characterized by the overproduction of cortisol. She is particularly interested in how stem cells respond to glucocorticoid-induced stress and their role in disease progression. Through her PhD work, she aims to uncover new therapeutic approaches by targeting stem cells as potential treatments for conditions associated with cortisol dysregulation. Additionally, her research delves into the broader impacts of oxidative stress on cellular development and the molecular pathways involved in stem cell differentiation and dysfunction. By exploring these areas, Mariangela aspires to contribute to new diagnostic and therapeutic strategies in the treatment of endocrine disorders and other related diseases.

Awards and Honors

While Mariangela’s career is still in the early stages, her potential has already been recognized within her academic and professional circles. In 2024, she is set to receive her qualification to practice as a biologist, marking a significant milestone in her professional development. Her research contributions have placed her in the spotlight for future awards and recognition in the field of molecular biology and stem cell research. Although her CV does not currently highlight specific awards, her consistent involvement in high-impact research projects, her PhD dissertation on stem cell dysfunctions, and her internships and research fellowships reflect a promising path toward earning significant honors in the years to come. Given her dedication to her field and her growing reputation, it is likely that Mariangela will receive further accolades as her research continues to make a lasting impact on the scientific community.

Conclusion

Mariangela Di Vincenzo is a promising candidate for the Best Researcher Award. Her focused, innovative research in stem cells and Cushing’s syndrome holds considerable promise for contributing to the field of human health. With her solid education, hands-on experience, and continuous involvement in significant research projects, she demonstrates a high level of scientific expertise. However, to further solidify her candidacy, focusing on increasing her publication record, broadening the reach of her work, and assuming leadership roles in her research group could make her an even more well-rounded and impactful researcher.

Publications Top Noted

  • Title: Monitoring cellular dynamics upon infection using a holotomography-based approach
  • Authors: Ilaria Nunzi, Gloria D’Achille, Nada Dhaouadi, Mariangela Di Vincenzo, Gianluca Morroni, Saverio Marchi, and others.
  • Year: The specific year of publication is not provided in your information, but you can visit the ORCID or Scopus profile to confirm.
  • Citations: 0 citations.

 

Edio Maldonado | Biochemistry | Best Researcher Award

Dr. Edio Maldonado | Biochemistry | Best Researcher Award

Profesor, Universidad de Chile, Chile

👨‍🔬 Dr. Edio Luis Maldonado Maldonado is an accomplished biochemist and molecular biologist specializing in transcription regulation and molecular biology. Currently, he serves as an Associate Professor at the University of Chile, where he contributes to the Cellular and Molecular Biology Program. With a research background that spans several prestigious institutions, Dr. Maldonado is recognized for his pioneering work in RNA polymerase II transcription factors, with his research widely published in prominent scientific journals.

Publication Profile

Scopus

Education

🎓 Dr. Maldonado’s academic journey began with a Bachelor’s in Sciences from Universidad Austral de Chile (1979-1983). He then pursued a Master’s in Sciences with a focus on Immunology at the same university (1983-1987). To deepen his expertise, he completed his Ph.D. in Biochemistry and Molecular Biology at the University of Medicine and Dentistry of New Jersey (UMDNJ) in the USA (1990-1996).

Experience

🏛️ Dr. Maldonado has held notable academic and research positions throughout his career. He started as an Assistant Professor at the Universidad Austral de Chile (1984-1987). After completing his Ph.D., he undertook postdoctoral research at the Howard Hughes Medical Institute, UMDNJ (1996-1997). He then joined the University of Chile as an Assistant Professor (1997-2004) before advancing to his current role as an Associate Professor at the Faculty of Medicine in the Cellular and Molecular Biology Program.

Research Interests

🔬 Dr. Maldonado’s research primarily revolves around the molecular mechanisms of gene transcription in mammalian cells, focusing on the role of RNA polymerase II and its associated transcription factors. His work sheds light on transcriptional regulation, providing insights that could impact various fields, including genetics and disease pathology.

Awards

🏆 Dr. Maldonado’s contributions to molecular biology and biochemistry have earned him respect in the scientific community, with his research frequently cited by peers and featured in high-impact journals.

Publications

“Factors involved in specific transcription by mammalian RNA polymerase II: RNA polymerase II associating protein 30 is an essential component of transcription factor IIF.”
📖 Journal of Biological Chemistry (1988), 2, pp. 975-990.
[Cited by other researchers]

“Factors involved in specific transcription by mammalian RNA polymerase II: factors IIE and IIF independently interact with RNA polymerase II.”
📖 Journal of Biological Chemistry (1989), 264, pp. 8913-8921.
[Cited by other researchers]

“A TATA-like sequence located downstream of the transcriptional initiation site is required for expression of an RNA polymerase II transcribed gene.”
📖 Genes and Development (1990), 4, pp. 1611-1622.
[Cited by other researchers]

“Factors involved in specific transcription by mammalian RNA polymerase II: role of factors IIA, IID and IIB during formation of a transcription competent complex.”
📖 Molecular and Cell Biology (1990), 10, pp. 6335-6347.
[Cited by other researchers]

“Direct Interaction between adenovirus E1a protein and the TATA-box binding transcription factor IID.”
📖 Proceedings of the National Academy of Sciences USA (1991), 88, pp. 5124-5128.
[Cited by other researchers]